共 105 条
[1]
Arnold O(2005)Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry Eur Neuropsychopharmacol 15 533-543
[2]
Saletu B(1961)Beck depression inventory (BDI) Arch Gen Psychiatry 4 561-571
[3]
Anderer P(2017)Essential Oils and Their Constituents: An Alternative Source for Novel Antidepressants Molecules 22 1290-274
[4]
Beck AT(2013)Massachusetts general hospital SAFER criteria for clinical trials and research Harv Rev Psychiatry 21 269-642
[5]
Ward C(2003)The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity QJM 96 635-1335
[6]
Mendelson M(2008)The clinical relevance of changes in the Montgomery–Asberg depression rating scale using the minimum clinically important difference approach Curr Med Res Opin 24 1329-82
[7]
de Sousa Damião(2017)Recent advances in predicting responses to antidepressant treatment F1000Research 6 619-45
[8]
Silva Rayanne(1959)Hamilton anxiety rating scale (HAM-A) J Med 61 81-381
[9]
Silva Epifanio(2002)Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database J Clin Psychopharmacol 22 40-376
[10]
Gavioli Elaine(1986)SAFTEE: a technique for the systematic assessment of side effects in clinical trials Psychopharmacol Bull 22 343-389